Ventana Medical Systems
Christian Roessler has extensive experience in quality management and research, currently serving as Manager and Sub-Chapter Lead for Strategic Quality Partnership in Pre-Market Quality at Roche Diagnostics since July 2014. In this role, Christian leads a team to establish quality partnerships across the assay portfolio. Previously, Christian managed the development of Class III IVD and Class C IVDR new IHC assays, overseeing project scoping and collaboration with pharmaceutical partners. Before joining Roche, Christian worked as a Senior Scientist and Scientist at Brookhaven National Laboratory, focusing on technology development in macromolecular crystallography, and served as a Postdoctoral Researcher at the University of Arizona, investigating protein structural changes. Christian holds a PhD in Biochemistry from the University of Arizona and a B.S. in Chemistry from Ithaca College.
This person is not in the org chart
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.